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ABSTRACT
Introduction: Enteric infections are common during
the first years of life in low-income countries and
contribute to growth faltering with long-term
impairment of health and development. Water quality,
sanitation, handwashing and nutritional interventions
can independently reduce enteric infections and growth
faltering. There is little evidence that directly compares
the effects of these individual and combined
interventions on diarrhoea and growth when delivered
to infants and young children. The objective of the
WASH Benefits study is to help fill this knowledge gap.
Methods and analysis: WASH Benefits includes two
cluster-randomised trials to assess improvements in
water quality, sanitation, handwashing and child
nutrition—alone and in combination—to rural
households with pregnant women in Kenya and
Bangladesh. Geographically matched clusters (groups
of household compounds in Bangladesh and villages
in Kenya) will be randomised to one of six intervention
arms or control. Intervention arms include water
quality, sanitation, handwashing, nutrition, combined
water+sanitation+handwashing (WSH) and WSH
+nutrition. The studies will enrol newborn children
(N=5760 in Bangladesh and N=8000 in Kenya) and
measure outcomes at 12 and 24 months after
intervention delivery. Primary outcomes include child
length-for-age Z-scores and caregiver-reported
diarrhoea. Secondary outcomes include stunting
prevalence, markers of environmental enteropathy and
child development scores (verbal, motor and personal/
social). We will estimate unadjusted and adjusted
intention-to-treat effects using semiparametric
estimators and permutation tests.
Ethics and dissemination: Study protocols have
been reviewed and approved by human subjects review
boards at the University of California, Berkeley,
Stanford University, the International Centre for
Diarrheal Disease Research, Bangladesh, the Kenya
Medical Research Institute, and Innovations for Poverty
Action. Independent data safety monitoring boards in
each country oversee the trials. This study is funded by
a grant from the Bill & Melinda Gates Foundation to
the University of California, Berkeley.
Registration: Trial registration identifiers (http://
www.clinicaltrials.gov): NCT01590095 (Bangladesh),
NCT01704105 (Kenya).
INTRODUCTION
Together, poor drinking water quality, sanita-
tion, hygiene (WASH) and nutrition are
leading risk factors for morbidity and mortal-
ity among children <5 years.1 Despite sub-
stantive progress spurred by the millennium
development goals to reduce these
poverty-related risks, millions of children are
born each year into environmental condi-
tions that hinder their ability to achieve their
full potential. Repeated insults from infec-
tion and undernutrition in the ﬁrst years of
life are believed to have profound negative
consequences on health, cognitive develop-
ment and human capital that span the life
course.2–4
The WASH Beneﬁts study includes cluster
randomised trials in Bangladesh and Kenya
to address three important research ques-
tions related to the early life impacts of
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WASH and nutritional interventions. The ﬁrst question
is whether WASH and nutritional interventions can
prevent linear growth faltering in the ﬁrst 2 years of life.
The second is whether greater reductions in diarrhoea
can be achieved by combining individual WASH inter-
ventions compared to delivering them in isolation. The
third is whether the combined WASH and nutritional
interventions jointly reduce diarrhoea or improve linear
growth more than each component alone. Below, we
brieﬂy summarise the rationale for the conduct of ran-
domised trials to address each of these areas of scientiﬁc
uncertainty.
Question 1: Can WASH and nutritional interventions
prevent early life linear growth faltering?
Children in low-income countries experience severe
linear growth faltering in the ﬁrst 18–24 months of life
that is thought to be preventable, at least in part, by
postnatal interventions.5 6 Interventions designed to
improve nutrition among very young children measure
length for age because it is a reliable, objective measure
associated with subsequent child development at older
ages.7 During this early window, undernutrition and
infection likely inﬂuence child development and human
capital through additional pathways besides linear
growth.8–10 Unfortunately, measuring child development
at very young ages is difﬁcult11 and documenting the
full range of intervention impact thus requires longer
term follow-up.4
In the ﬁrst years of life, intervention trials and obser-
vational studies have implicated poor diet and infectious
diseases as likely causes for a large share of child under-
nutrition.8 12 13 Interventions to promote breastfeeding,
improve complementary feeding practices, or provide
nutritional supplements can lead to small improvements
in nutritional indicators and length for age,14–16 particu-
larly among children who are at highest risk for severe
stunting.17 18 Nevertheless, effects of nutritional inter-
ventions on linear growth (upper bound of 95% CI
+0.79 Z-scores)19 fall far short of the median growth def-
icits observed in Sub-Saharan Africa and Southeast Asia,
which are on the order of –2.0 Z-scores.6
One hypothesis for the inability of nutritional interven-
tions alone to prevent a large share of growth faltering by
age 24 months is that symptomatic and asymptomatic
infections are important contributors to undernutrition.
Symptomatic infection is common during the ﬁrst years
of life in low-income countries: on average, children
under 24 months suffer from three to four episodes of
acute diarrhoea each year20; respiratory infections and
other infectious diseases, such as malaria, are also
common in many settings. Observational studies show
that repeated episodes of diarrhoea or parasitic infection
are associated with increased risk of stunting8 21–27 and
subsequent cognitive deﬁcits in childhood and later in
life.4 28 29 Possible mechanisms for enteric infections
leading to growth faltering include reduced nutrient
absorption through lower intestinal contact time during
episodes of acute diarrhoea, greater nutrient losses from
persistent diarrhoea (eg, zinc) or intestinal bleeding (eg,
hookworm infection), reduced appetite, and diversion of
energy and nutrients from growth to the immune system
to ﬁght the infection.
In addition to symptomatic infection, a subclinical
condition called environmental enteropathy (EE), also
known as tropical enteropathy, may also contribute to
early life growth faltering.30–32 The aetiology of EE
remains unknown, but the condition is generally charac-
terised by a set of physiological changes to the small
intestine’s epithelial layer, which include villous atrophy,
crypt hyperplasia, reduced absorptive capacity, increased
permeability and inﬂammatory cell inﬁltration.33 The
causes are most likely related to repeated ingestion of
pathogenic bacteria and an altered composition of the
intestinal microbiota, which together lead to chronic
enteric inﬂammation.32 Children with EE are believed
to have impaired growth through two mechanisms: (1)
reduced nutrient absorption due to decreased surface
area in the small (upper) intestine and (2) elevated
intestinal permeability, which increases translocation of
antigenic molecules that stimulate the immune system
and divert energy from growth. The combined effect of
these two processes may impair a child’s ability to effect-
ively utilise nutrients in the existing diet for growth and
development. EE is thought to be highly prevalent in
low-income countries34 and develops early in life: by age
8 months, 95% of a birth cohort in the Gambia showed
signs of EE and on average children in the cohort exhib-
ited signs of EE during 75% of their ﬁrst year of life.31
Studies of Peace Corps volunteers and immigrant popu-
lations have demonstrated that intestinal malabsorption
and permeability typically return to normal levels within
1–2 years after individuals move from highly contami-
nated environments to cleaner environments.35 36 Since
community-based studies that measure intestinal struc-
ture through biopsies would be extremely difﬁcult, inves-
tigators typically rely on biomarkers of intestinal
permeability, inﬂammation and immune system stimula-
tion as measures of subclinical EE.31 37 38
It is possible that improved nutrition alone can reduce
the negative effects of a limited number of episodes of
infection on growth due to the improved ability of better-
nourished children to ﬁght off enteric infections and
exhibit catch-up growth during the convalescent
period.21 28 39–42 Effective nutritional interventions may
be able to prevent or shorten the duration of EE via
several mechanisms, such as (1) strengthening epithelial
barrier integrity and the immune response; (2) compen-
sating for malabsorption, reallocation or losses of key
nutrients during infection; (3) accelerating gut repair fol-
lowing infection; and (4) favouring the growth of beneﬁ-
cial gut microorganisms.39 While it is possible that
nutritional interventions alone may prevent or shorten
the duration of EE, the limited evidence to date has been
mixed,33 with some evidence for improvements in gut
function following vitamin A,43 alanyl-glutamine
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supplementation44 and zinc supplementation,45 46 but
there is no evidence for gut function improvement in
trials that delivered probiotics,47 glutamine supplementa-
tion,48 omega-3 fatty acids49 or richly fortiﬁed comple-
mentary foods.50 As noted above, in many studies
nutritional interventions have been insufﬁcient to com-
pletely prevent growth faltering in low-income popula-
tions and in the context of repeated or chronic infection,
improved nutrition may only be able to mitigate—but not
necessarily overcome—some of the effects of enteric
infection on growth. If acute infections and subclinical
EE contribute signiﬁcantly to growth faltering, then inter-
ventions to reduce enteric infections during the ﬁrst
years of life would be expected to improve linear growth,
perhaps independent of nutritional interventions.
Unlike the large literature on child nutritional inter-
ventions, we are aware of only 10 studies that measure
the effect of WASH interventions on child growth; a
forthcoming systematic review51 may perhaps identify
more. Four studies have found no improvement in
linear growth as a result of WASH interventions, despite
demonstrating reductions in caregiver-reported diar-
rhoea in most cases.9 52–56 A small randomised trial that
enrolled children <12 months and delivered handwash-
ing promotion in Kathmandu slums additionally found
no improvements in EE biomarkers.53 The authors
hypothesised that handwashing alone was inadequate as
sufﬁcient protection from the slum environment to
change intestinal physiology and suggested that more
comprehensive environmental improvements may be
necessary to reduce EE and improve growth.
Six studies have found positive associations between
improved WASH conditions and child growth. Multiple
cross-sectional or case–control studies found that
young children living in households with improved sani-
tation and water supply had better linear growth.26 57 58
A prospective birth cohort study in periurban Peru
found that children living in households with home
water supply and sewerage connections were 1 cm taller
by age 24 months compared with children in households
without them, and the effects of water supply and sewer-
age conditions were not mediated entirely by reductions
in diarrhoea.59 A water quality intervention trial in
rural Kenya found an average linear growth increase of
0.8 cm among children <5 years old after 1 year of
exposure.60–62 A prospective cohort from rural
Bangladesh enrolled in a pilot for this study found that
children raised in households with improved sanitation,
hygiene and water quality conditions had lower levels of
parasite infection, better growth and improved EE bio-
markers compared to children raised in households
without such access.63 A trial to assess the impact of
rural sanitation on diarrhoea includes length for age as
a secondary outcome but is still underway.64 Taken
together, the mixed evidence to date does not conclu-
sively link improved WASH conditions with improved
child growth and the ﬁeld would beneﬁt from additional
efﬁcacy studies.
Question 2: Are combined WASH interventions more
effective than single interventions?
In addition to quantifying the independent effects of
WASH interventions, an important question is whether
and how to combine sanitation, water quality and hand-
washing promotion interventions to cost-effectively
achieve health gains. Many implementing groups have
publicly embraced the notion that combining interven-
tions to improve water quantity, water quality, sanitation,
and hygiene results in added beneﬁts. This claim is
based, in part, on observational studies26 58 65 66 and the-
oretical modelling of pathogen transmission path-
ways.67 68 However, the limited available evidence from
randomised trials does not support this approach. In the
only randomised controlled trial speciﬁcally designed to
evaluate combined interventions, the two interventions
evaluated were point-of-use water treatment and hand-
washing promotion with soap; individually, each inter-
vention reduced child diarrhoea (51% and 64%
reduction), but there was no additional reduction in
diarrhoea among children exposed to both interven-
tions (55% reduction).54 These ﬁndings are consistent
with the results of a meta-analysis of published interven-
tions to improve WASH, which found that combined
interventions led to no greater reduction in diarrhoeal
disease than single interventions.69
For WASH programmes, single interventions are less
expensive and easier to scale than combined interven-
tions. By complicating communication and behaviour
change, combined interventions can potentially diminish
the overall effect achievable from a single intervention.70
Understanding the marginal beneﬁts of sanitation, water
treatment and handwashing in the absence and presence
of each of the other interventions will, therefore, be
important for policy-makers (1) when deciding overall
budgets for sanitation, water and handwashing; and (2)
when weighing the trade-offs between allocating
resources to an intense, expensive approach combining
multiple interventions in a single site, or choosing the
most cost-effective interventions and rolling them out at
scale. This same reasoning applies to our third research
question.
Question 3: Are there larger effects on diarrhoea or linear
growth from combining (A) nutritional interventions with
(B) a combined water, sanitation and handwashing
intervention compared to each component alone?
In the 1960s, Scrimshaw et al71 proposed a theory that
repeated infections interact with poor nutrition to cause
a cycle of infection and malnutrition. Consistent with
this earlier work, McDade72 outlined a life history
theory of immune function in which he posited that
infants face a resource allocation trade-off between
maintenance (ﬁghting infection and physiological
repair) and growth. During infection, the immune
system diverts energy and nutrients away from growth; a
developing infant prioritises survival and maintenance
over growth. When resources are limited, the absolute
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level of energy or nutrients available to infants can be a
major determinant of growth and physiological repair.
An impaired gut in a child without access to sufﬁcient
energy or nutrients will further suffer from impaired
healing, with subsequent decline in gut function and
nutrient absorption for growth; thus begins a vicious
cycle between infection and malnutrition.71 73 74 The
potential contribution of infection to malnutrition and
mortality risk was recently illustrated in a dramatic 35%
reduction in all-cause mortality among severely malnour-
ished Malawian children after the provision of prophy-
lactic antibiotics.75
Dewey and Mayers39 reviewed the evidence for the
potential interaction between nutrition and infection on
early child growth. The review identiﬁed just one study
that suggested that infections could reduce the effective-
ness of nutritional interventions and four trials that
demonstrated that improved nutrition could limit the
negative consequences of infection. The authors con-
cluded that the potential interaction between nutrition
and infection control should be a priority for research,
which echoes earlier calls for additional research in this
area.33 34 The only study to date that we are aware of that
was explicitly designed to test for interaction between
infection control and improved nutrition was the
Narangwal Nutrition Project, conducted in Punjab, India,
between 1968 and 1973.10 76–78 The 10-village study (2900
newborns) was a factorial trial that randomised villages to
control, improved medical services, improved nutrition or
their combination. The nutrition intervention included
growth monitoring, food supplementation for children
who were not growing well and nutrition education. The
medical care intervention improved access to vaccines and
morbidity surveillance for acute illness. Both nutritional
and medical service villages also received prenatal care for
pregnant mothers, which included iron and folic acid sup-
plements as well as food supplements for mothers who
were underweight. The study found that the medical ser-
vices intervention improved height and weight compared
to control, and that the nutritional services intervention
improved height and weight even more. The study found
no additional beneﬁt in combining nutrition and medical
services above the nutritional services alone with respect to
height and weight. Although international guidelines for
infant and young child-feeding practices published by
UNICEF, WHO and the Alive and Thrive initiative all
include handwashing recommendations,79–81 the degree
to which additional infection control measures could com-
plement nutrition programmes remains an important
knowledge gap.
Objectives of the WASH Benefits study
Given the likely long-term negative consequences of
undernutrition and infection during a child’s ﬁrst years,
the global development community would beneﬁt from
rigorous evidence about the effects of single and com-
bined WASH and nutritional interventions on child
illness and growth. As outlined above, there remains
substantial uncertainty about which interventions or
combination of interventions are most effective. The
WASH Beneﬁts study includes two highly comparable
cluster randomised trials in rural Bangladesh and Kenya
to help ﬁll these knowledge gaps. The intervention trials
include single and combined interventions in sanitation,
water quality, handwashing and nutrition. Each interven-
tion has been developed over multiple years of formative
research. The two trials share the following scientiﬁc
objectives, which will contribute evidence towards the
identiﬁed evidence gaps.
Primary scientiﬁc objectives
1. Measure the impact of sanitation, water quality, hand-
washing and nutrition interventions on child diar-
rhoea and linear growth after 2 years of exposure.
2. Determine whether there are larger reductions in
child diarrhoea when providing a combined water,
sanitation and handwashing intervention compared
to each component alone.
3. Determine whether there are larger effects on child
diarrhoea and linear growth from combining (A) a
comprehensive child nutrition intervention with (B)
a combined water, sanitation and handwashing inter-
vention compared to each component alone.
Secondary scientiﬁc objectives
1. Measure the impact of a child nutritional interven-
tion and household environmental interventions on
EE biomarkers, and more clearly elucidate this poten-
tial pathway between environmental interventions
and child growth and development.
2. Measure the impact of sanitation, water quality, hand-
washing and nutritional interventions on intestinal
parasitic infection prevalence and intensity.
3. Measure the association between parasitic infection
and other measures of enteric health, including
acute diarrhoea and EE biomarkers.
To achieve these objectives, the studies will enroll
pregnant women and their children born within
approximately 6 months of the baseline survey. The
study will measure linear growth and caregiver-reported
diarrhoea, biological markers of EE, intestinal parasite
infections and child development in the cohort over the
ﬁrst 24 months of exposure to the intervention.
METHODS AND ANALYSIS
Overview of the design
The Bangladesh trial is led by the International Center
for Diarrheal Disease Research, Bangladesh (ICDDR,B);
the Kenya trial is led by Innovations for Poverty Action
(IPA) and the Kenya Medical Research Institute
(KEMRI). Both trials include six intervention arms and a
double-sized control arm (ﬁgure 1). In Bangladesh, the
unit of randomisation is a group of compounds visited by
a single local promoter and separated by at least a 15 min
walk. Bangladesh clusters consist of eight proximate
household compounds that meet our eligibility criteria
within a village. In Kenya, clusters consist of one or two
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adjoining administrative villages with at least six eligible
pregnant women. The studies enrol pregnant women
and their children who are born within approximately
6 months of the baseline survey. We will follow the closed
cohort longitudinally and measure primary outcomes at
12 and 24 months after initiating the intervention.
The design includes a large number of clusters per
arm with a small number of children per cluster, which
was motivated by three, inter-related considerations: (1)
WASH interventions need to be delivered at the cluster
level because the promotion activities are inherently
community level, (2) there are potential interactions
between adjacent households with respect to behaviour
and infectious disease and we wish to maintain inde-
pendent units for randomisation, and (3) at the time
our study enrols a cluster and initiates an intervention,
pregnant women are relatively scarce. The large study
population spread over a wide geographic area means
that we will measure intervention effects over heteroge-
neous environmental conditions.82 The design is opti-
mised to measure group-level differences in our primary
outcomes. The infrequent measurements in WASH
Beneﬁts will mean that we will not characterise infec-
tious outcomes (eg, diarrhoea and parasitic infections)
well for individual children if the outcomes vary tempor-
ally within children.83
Participant eligibility criteria, study setting and enrolment
strategy
Participant eligibility criteria
In both countries, the trials enrol pregnant women iden-
tiﬁed in community-based surveys who expect to deliver
in the 6 months following enrolment based on date of
last menstruation. The study will enrol all children born
in study clusters in the 6 months following the baseline
survey (some target children will be born after 6 months
due to inaccuracies in gestational age using reported
date of last menstruation). Our target sample size of
pregnant women at enrolment is 5760 in Bangladesh
and 8000 in Kenya. The Kenya cohort will be larger
because we expect to ﬁnd more variation in child length
for age than in Bangladesh (sample size details below).
Within study compounds, the study enrols all children
<36 months at baseline to measure diarrhoea outcomes
over the study period; the study measures diarrhoea out-
comes in a wider age group because older children are
still at high risk for diarrhoeal disease.20
In both countries, compounds consist of multiple
households (typically 3–10 in Bangladesh and 1–4 in
Kenya), usually comprising blood relatives, who share a
common courtyard. Compounds are eligible to partici-
pate if (1) they have a pregnant woman and (2) the
woman plans to stay in the village for the next
Figure 1 Summary of the overall study design in both countries, including cluster and target child enrolment in each arm.
Growth and diarrhoea measurements will take place at 15 and 27 months following enrolment, which corresponds to 12 and
24 months following initial intervention delivery due to a 3-month lag between enrolment and intervention implementation. C,
control; H, improved handwashing; N, improved nutrition; S, improved sanitation; W, improved water quality; WSH, combined
improvements in water quality, sanitation and handwashing; WSH+N, combined improvements in water quality, sanitation,
handwashing and nutrition.
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12 months. The study excludes households who do not
own their home to help mitigate attrition during
follow-up. The Kenya trial excludes villages that have
chlorine dispensers at water sources installed by pro-
grammes separate from the present study. In
Bangladesh, the study excludes households who report
high iron in their drinking water most of the year
because pilot studies showed it was difﬁcult to maintain
the appropriate chlorine residual for continued disinfec-
tion in high-iron water. In cases in which the respondent
is unsure about iron content, ﬁeld staff check the water’s
chlorine demand using Aquatabs and a digital Hach
Pocket Colorimeter II; if residual chlorine is below
0.2 mg/L after 30 min staff exclude the household.
Within a study compound, the studies enrol pregnant
women and children from the following age groups
1. Children in utero at enrolment (target children): all chil-
dren born to enrolled mothers within approximately
6 months of the baseline survey.
2. Children 18–27 months old at enrolment (specimen collec-
tion): older children living in the compound and
aged 18–27 months at enrolment will be eligible for
stool and blood specimen collection. This age
window reﬂects the age window of the target children
at the ﬁnal study measurement and serves as a base-
line measure for the study population.
3. Children aged <36 months at enrolment (diarrhoea): All
children aged <36 months living in the compound
are eligible for caregiver-reported diarrhoea
measurement.
4. Additional children born into study compounds after
6 months: We will enrol children born into study com-
pounds who are too young to meet our enrolment
criteria (group 1, above), deliver interventions to
them according to randomised assignment and
measure anthropometry and diarrhoea at follow-up
surveys. These additional enrolees will not be
included in the primary analysis because very young
children may not be exposed to intervention for sufﬁ-
cient amount of time to expect to see impact on our
primary outcomes (particularly length for age).
However, the additional young children will provide
information (in exploratory analyses) about the
effect of established interventions on very young
infants.
Field staff discuss the prospect for participation in the
study with adults in each compound, including the
mother/caregiver of the target infants. After providing
time for discussion among the compound residents, a
member of the ﬁeld team seeks formal informed
consent from pregnant women.
Bangladesh setting and enrolment
The Bangladesh trial is located in Gazipur, Mymensingh
and Tangail districts. These three districts are located in
the ﬂoodplain of central Bangladesh where the majority
of the rural population is engaged in agriculture. The
majority of the population uses shallow tubewells for
drinking water, which are known to be frequently con-
taminated with faecal indicator bacteria.84 Enrolment
commenced in June 2012. The study has enrolled com-
pounds in communities that meet the following criteria.
▸ Located in a rural area.
▸ Drinking water with low levels of iron (<1 mg/L on
average) and arsenic (<50µg/L on average) as docu-
mented in the collaborative assessments by the
Government of Bangladesh and the British
Geological Survey. Water chemistry eligibility criteria
were used because pilot studies indicated that when
iron or arsenic levels were high the chlorine demand
for household water treatment was unpredictable.
▸ The Government of Bangladesh, international non-
government organisations working in Bangladesh and
local government authorities report that no major
water, sanitation or focused nutrition programmes
are currently operating or planned in the area in the
next 2 years.
▸ Not located in haor areas (areas completely sub-
merged during the monsoon season).
Each study cluster includes a group of compounds
with eight eligible pregnant women. The compounds
within a cluster are located sufﬁciently closely together
so that a single promoter can reach each of the partici-
pating compounds by walking. If the compounds were
too dispersed for a promoter to reach all of them on
foot, they will then not be enrolled in the study. More
than one cluster could be enrolled in a single village but
clusters within the same village need to be separated
from each other by a minimum of 15 min walking
distance.
Kenya setting and enrolment
The Kenya trial is located in rural areas of 10 districts in
Bungoma, Kakamega and Vihiga counties in the western
part of the country. The region is populated mainly by
subsistence farmers. Unimproved latrine coverage is
high (at least 85%) and our pilot study in the region
estimated that among children <27 months old, 11%
had diarrhoea in the preceding 2 days. Very few (<5%)
households have piped water and the majority of house-
holds report obtaining drinking water from sources,
such as protected springs, where chlorination has previ-
ously been shown to be effective.85 Enrolment com-
menced in November 2012. The study region contains
over 2000 villages, from which study villages were
selected to form clusters using the following criteria:
▸ Located in a rural area (deﬁned as villages with <25%
residents living in rental houses, <2 gas/petrol sta-
tions and <10 shops);
▸ Not enrolled in ongoing WASH or nutrition
programmes;
▸ Majority (>80%) of households do not have access to
piped water into the home;
▸ At least six eligible pregnant women in the cluster at
baseline.
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Description of the interventions
Overview of the intervention approach and assumptions
The WASH Beneﬁts study has focused on identifying
and testing water, sanitation, handwashing and nutri-
tional interventions that have strong potential to reduce
infection and malnutrition during the ﬁrst years of life.
WASH Beneﬁts is designed to measure intervention
effects under conditions of high uptake in our target
populations since our central hypotheses have not been
tested rigorously in randomised studies. The enabling
technologies and behavioural intervention packages
were developed in the target populations over a 2-year
period before the start of the trials. Details of the behav-
iour change theoretical frameworks and methods used
in each country will be published in separate, forthcom-
ing articles. Local promoters who are residents of the
study villages deliver the interventions at the cluster
level; each promoter completes at least 5 days of training
and also attends refresher courses periodically through-
out the study period. Promoters visit and counsel study
compounds weekly in the early phase of intervention,
with visits declining in frequency over time; we anticipate
visits as infrequent as one per month after 1 year of
intervention.
The environmental interventions in this study focus
on modifying the compound environment to reduce
infant exposure to enteric pathogens. The interventions
focus on compound-level modiﬁcations because we
assume that the dominant transmission pathways for the
infants in our study will be within the compound. Since
we expect on average 8–10 household-compounds with
eligible children per study cluster, we expect to inter-
vene in a small fraction of each community. While
point-of-use water quality, hygiene and nutrition inter-
ventions operate at a household level, some sanitation
interventions may require wider coverage in a neigh-
bourhood, community or other larger environment in
order to effectively mitigate personal exposure. However,
cost and logistical limitations prevented us from extend-
ing implementation beyond the compound.
Furthermore, a pilot study suggested that the compound
was a relevant unit of intervention for modifying infant
exposure to environmental conditions.63
Control
It is possible that the simple act of regular visits by inter-
vention promoters could lead to improvements in the
primary outcomes through unknown channels that are
independent of WASH or nutrition interventions. The
WASH Beneﬁts team discussed this possibility extensively
in the year preceding the trials and the teams agreed to
pursue slightly different strategies in the two countries.
The Bangladesh team concluded that their intervention
behaviour change model is so tightly integrated into the
enabling technology components that the effect of a
visit is inseparable from the WASH and nutrition inter-
ventions themselves; moreover, it is fairly common for
mothers in the study area to be visited by community
promoters associated with other programmes. The
control arm in Bangladesh will be a ‘passive’ control,
meaning there is no promotion or intervention activity
during the study.
The Kenya team was more concerned about the possi-
bility of the promotion visits leading to changes in beha-
viours not related to WASH or nutrition that could
nonetheless affect the primary outcomes since promoter
visits are atypical in the Kenyan study area. For this
reason, the Kenya team decided to include promoters in
their control arm and to add a simple activity across all
arms of the study: monthly measurement of mid-upper
arm circumference (MUAC) or measuring the pregnant
woman’s belly circumference prior to the birth. The key
assumption for the Kenya design is that whatever
non-WASH-related or nutrition-related behaviour
changes occur in the intervention arms will also occur
in the control arm. The Kenya control arm promoters
do not promote any WASH, or nutrition messages, and
strictly engage in measuring child MUAC and mother
belly circumference. In all arms, children >6 months old
with MUAC <115 mm are classiﬁed as severely malnour-
ished and are referred to treatment (details mentioned
below in Referral guidelines).
Water quality
The Bangladesh study delivers a 10 L, insulated water
storage vessel and a free supply of chlorine tablets
(Aquatabs brand, sodium dichloroisocyanurate) to
enrolled households to improve the microbiological
quality of their drinking water.86 The Kenya study installs
chlorine dispensers within the cluster boundary at
public water sources used by study participants. All com-
munity members will be able to use the dispensers. After
ﬁlling their water collection container (typically a 20 L
plastic jerry can) at the source, users can place the con-
tainer under the dispenser and turn a knob to release
3 mL of 1.25% sodium hypochlorite, an amount
designed to yield 2 mL/L of free chlorine residual after
30 min for 20 L of water.87 The Kenya study also includes
community level promotion of dispenser use and all
households in the study compound receive bottles of
sodium hypochlorite (6 months’ supply) to facilitate
householders’ water treatment during periods when
they rely on rainwater harvesting (common during the
rainy season) or if they use a water source in which a dis-
penser has not been installed. In both countries, the
behaviour change strategies target the consistent provi-
sion of treated water to all children living in the
household.
Sanitation
Both the Bangladesh and Kenya studies include three
enabling technologies in the compound-level sanitation
intervention with the goals of reducing children’s expos-
ure to faeces in the household environment and increas-
ing latrine use: (1) a locally developed sani-scoop
dedicated to the removal of child and animal faeces
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from the compound,88 (2) plastic child potties for chil-
dren aged 6 months and older until they use the latrine
and (3) a new or upgraded latrine for each household
in the compound. In Bangladesh, latrines are upgraded
to a dual pit latrine with a water seal and super struc-
ture. In Kenya, plastic latrine slabs that include a tightly
ﬁtting hole-cover are installed to improve existing
latrines that have a mud or wood ﬂoor. Simple pit
latrines (unlined pits with an earthen superstructure
and the plastic slab) are constructed in the compounds
of study participants who do not have access to a latrine.
The behaviour change strategies in both countries target
the use of the latrine for defaecation and the safe dis-
posal of faeces by all households in the compound to
prevent contact by young children.
Handwashing
Both country studies install two handwashing stations for
enrolled households: one near the latrine and one near
the cooking area. In Bangladesh, handwashing stations
include a locally made bucket with a tap ﬁtting (40 L
near the latrine and 16 L near the cooking area), a
stool, a bowl and a bottle to dispense soapy water. In
Kenya, handwashing stations are constructed from
locally available materials and include a dual tippy-tap
design with independent pedals attached to two 5 L
jerry cans of clean water and soapy water.89 In both
countries the studies provide soap to families free of
charge to replenish the handwashing stations. The
behaviour change strategies of the intervention target
handwashing with soapy water messaging at two critical
times for caregivers: after defaecation/cleaning the
child’s anus and before food preparation.90 Promoters
frame the concept of handwashing as a nurturing behav-
iour facilitated by the ease and convenience of a nearby
handwashing station.91
Combined water+sanitation+handwashing
In both countries, the combined water+sanitation+hand-
washing (WSH) intervention integrates all intervention
components from the water quality, sanitation and hand-
washing arms. Intervention promoters sequence the
interventions so that they are not introduced at the
same time. In Bangladesh, the interventions are deliv-
ered sequentially in the following order: sanitation,
handwashing and water treatment, with a minimum of
21 days between each start date. In Kenya, all interven-
tion technologies aside from latrine construction are
provided at the same time but the behaviour change
counselling is rolled out in the following sequence
approximately spaced around 2 weeks apart: handwash-
ing and basic water treatment, sanitation, in-depth water
treatment. The provision of latrines can range from one
to several weeks after the start of work in a cluster in
Kenya. The behaviour change strategy emphasises the
interconnected aspect of WASH and the need to prac-
tice all behaviours in order to beneﬁt from them.
Nutrition
In both countries, the nutrition intervention strategy
targets age-appropriate behaviours (pregnancy to
24 months) including use of lipid-based nutrient supple-
ments (LNSs; aged 6–24 months). The behaviour change
counselling is modelled after the Guiding Principles for
Complementary Feeding of the Breastfed Child,80 the
UNICEF Program Guide for Infant and Young Child
Feeding Practices81 and the Alive and Thrive initiative.79
Target behaviours include (1) practice exclusive breast-
feeding from birth to 6 months of age and introduce com-
plementary foods at 6 months of age while continuing to
breastfeed; (2) continue breast feeding as you did before
receiving study-provided nutritional supplements; (3)
provide your child micronutrient-rich foods, such as meat,
ﬁsh, eggs, and vitamin A rich fruits and vegetables
(adapted to locally available food examples); and (4) feed
your child complementary foods at least 2–3 times per day
when 6–8 months old and 3–4 times per day when 9–
24 months old.
When target children are between 6 and 24 months
old, intervention promoters will deliver monthly supplies
of LNS. The LNS used in the study is a next generation
version of Nutributter.92 Online supplementary appendix
1 includes the speciﬁc LNS formulation. LNS is adminis-
tered daily using 10 g sachets that can be mixed into pre-
prepared meals (eg, porridge) or consumed directly
from the sachet; a child eats two sachets per day. LNS is
intended to supplement—and not replace—breastfeed-
ing and locally available complementary foods, by provid-
ing 118 kcal/day and including a broad suite of essential
fatty acids and micronutrients at dosages appropriate for
children in this age group.92 It has an 18-month shelf life,
does not spoil at high temperatures and costs as little as
US$0.08/day. Reported adherence has been 88% of days
in controlled trials,14 in part due to the ease of incorpor-
ating it into existing feeding routines. Breastfeeding is
highly prevalent in both populations based on pilot
studies and so we have focused on supplements that
would not replace this essential source of nutrition.93 94
In Kenya, the trial will provide LNS to older, age-eligible
siblings (6–24 months) living in study households to
prevent potential sharing of LNS with older siblings. The
Bangladesh trial will deliver LNS only to target children
because older, age-eligible siblings are rare in the study
population.
Nutrition+combined WSH
In both countries, the nutrition+combined WSH arm will
include the interventions delivered in the nutrition and
combined WSH arms. The nutrition intervention is deliv-
ered in parallel with the WSH interventions according to
the stage of pregnancy and age of the target child.
Intervention monitoring
Given the importance of good uptake (also called
take-up or compliance) for the success of the trial, it is
essential for the team to have early and frequent
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feedback on intervention uptake. If an intervention has
poor uptake, the team then needs to consider modifying
or redoubling implementation efforts in that arm. To
preserve external validity, each country team will docu-
ment any adaptive changes used to modify the interven-
tion. Investigators will be blinded to outcomes from the
trial, so any adaptation to intervention will be based
solely on information about intervention implementa-
tion and uptake.
Both country teams have in place a detailed imple-
mentation monitoring system. One of the outputs from
the monitoring system is a summary of whether the
implementation has achieved a limited set of critical
benchmarks (see online supplementary appendix 2);
benchmarks are intended to ﬂag serious problems in
implementation. If any of the uptake measures falls
below its critical benchmark, then a qualitative team will
review the monitoring and process documentation in
the low-performing area, visit the site of the low uptake,
meet with intervention promoters, supervisors and study
participants and troubleshoot the cause of the low
uptake. Because the interventions have each been
piloted and the pilots achieved these benchmarks of
uptake, we expect that uptake below the benchmark will
indicate a problem where the intervention was not
implemented as planned, and the investigation will iden-
tify what additional training or other support is required
to achieve high intervention uptake.
Additional principles that we will follow with respect to
adapting the interventions include:
1. If we identify easily ﬁxable problems in an interven-
tion that we expect will improve uptake, then we will
make the change uniformly in the study population.
2. If we identify a problem in an intervention arm and
devise a solution, the solution must be implemented
in all clusters assigned to that intervention to ensure
that we do not differentially modify the intervention
on a subsample of the population.
3. Since WASH Beneﬁts is an efﬁcacy trial, we will
replace broken hardware in our study population.
4. We will maintain a detailed record of the timing and
scope of any changes to the interventions (if any).
Outcomes
Primary outcomes
Primary outcomes include length-for-age Z-scores (LAZ)
measured 24 months after intervention initiation in
target children and diarrhoea prevalence in compound
children <36 months old at enrolment. Child age will be
determined using birthdates veriﬁed when possible
using vaccination cards. Following standard protocols for
anthropometric outcomes measurement,95 96 pairs of
trained anthropometrists will measure recumbent length
(accurate to 0.1 cm) and weight without clothing (accur-
ate to 0.1 kg) in triplicate. The median of the three mea-
surements will be used in the analysis.97 We will measure
diarrhoea at baseline among children <36 months old
and again 12 and 24 months after intervention initiation
using a deﬁnition of ≥3 loose or watery stools in 24 h or
≥1 stool with blood based on caregiver-reported symp-
toms98; we will use a 7-day recall period unless we ﬁnd
differential recall errors by the randomised group, in
which case we will use a 2-day recall period.99 100
Secondary outcomes
Secondary outcomes include two additional measures of
linear growth, child development measures and measures
of EE. We will calculate differences between groups in LAZ
at the 12-month measurement and stunting prevalence
(LAZ<–2) at the 24-month measurement. At the 24-month
visit, we will measure child development in communica-
tion, gross motor and personal/social domains using the
Extended Ages and Stages Questionnaire11 101; the instru-
ment has been adapted to each study population, relies on
caregiver’s report and has been used in many low-income
countries.102 We will compare groups for each domain
independently and overall by summing scores across
domains. In a subsample of up to 1500 children across
four arms of each trial, we will measure EE biomarkers at
3, 12 and 24 months following intervention initiation
(ﬁgure 2); assays planned include: urinary lactulose-
to-mannitol ratio,103 faecal myeloperoxidase,104 faecal
α-1-antitrypsin,105 faecal neopterin106 and plasma total
IgG.37
Additional outcomes
The study will collect stool specimens from seven target
children per cluster at the 24-month visit and from an
older child living in the compound (ﬁgure 3), and will
test specimens for soil-transmitted helminths (Ascaris lum-
bricoides, Trichuris trichiura, hookworm) using the
Kato-Katz method107 and protozoans (Giardia lamblia,
Cryptosporidium parvum, Entamoeba histolytica) using PCR
methods (Bangladesh) and commercial ELISA kits
(Kenya). Online supplementary appendix 3 includes a
full list of tertiary outcomes. In a subsample of house-
holds in which the study measures EE biomarkers, we will
also measure markers of environmental faecal contamin-
ation to help trace the causal path between the interven-
tions and outcomes. Environmental contamination
measures will include enumeration of faecal indicator
bacteria (Escherichia coli) in household-stored drinking
water, on child toy balls and child hand rinses. In add-
ition, the study will collect quantitative measures of ﬂy
density at the latrine and the food preparation area.
Referral guidelines
The study will refer participants for treatment at appro-
priate local government healthcare providers if we
observe any of the three following outcomes: soy or nut
allergies related to LNS, acute malnutrition and intes-
tinal parasite infection (described below).
Soy or nut allergies related to LNS
In the LNS arms, intervention promoters will recom-
mend that caregivers stop using LNS and notify one of
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the study staff immediately should their child have any
adverse reactions shortly after ingesting the supplement
(such as vomiting, stomach pain, rash and breathing
problems with wheezing). In the event of an adverse
reaction, study staff will assess the child’s condition and,
if necessary, provide transport to the closest medical
facility for treatment.
Acute malnutrition
In the anthropometry and enteropathy assessment
survey, children who are found to be acutely malnour-
ished based on WHO/UNICEF criteria (severely wasted
[weight for length Z-score <−3] and/or bipedal
oedema) will be referred to the appropriate existing
treatment programmes in each country. In Kenya, where
promoters measure MUAC each month for all target
children, children >6 months with MUAC <115 mm will
be considered severely malnourished and will be
referred to treatment.
Intestinal parasites
All children who provide a stool specimen in the
24-month survey will be offered deworming medication,
which is consistent with national standards in both
countries.
Randomisation and blinding
The trials will randomly allocate clusters to each inter-
vention arm of the study in equal proportion along with
a double-sized control arm. The randomisation is pair-
matched by geography, with adjacent clusters rando-
mised in blocks. The rationale for using geography to
match the randomisation is that it is logistically feasible;
it may add efﬁciency to our effect estimation if geog-
raphy is strongly correlated with our outcomes and it
will help ensure that the different arms are balanced
with respect to characteristics and events that are spa-
tially clustered. In Bangladesh, the trial will randomise
groups of eight geographically proximate clusters to one
of the six intervention arms or the double-sized control
arm with allocation probabilities of 2/8 for control and
1/8 for each intervention arm. In Kenya, the randomisa-
tion is identical but includes nine proximate clusters in
each block with allocation probabilities of 2/9 for active
control, 1/9 for each intervention arm and 1/9 for a
potential passive control (not yet funded). Clusters allo-
cated to a passive control arm in Kenya will enable the
study to measure the effect of regular visits to the study’s
active control arm, if any, pending future funding.
The randomisation sequence generation and alloca-
tion for both trials will be conducted by the coordinat-
ing team at the University of California, Berkeley, using
a random number generator in Stata V.12 (StataCorp,
Figure 2 Summary of EE subsample in both countries, including cluster and target child enrolment in each arm. The EE
subsample includes an equal number of clusters and target children from four arms of the study. C, control; EE, environmental
enteropathy; H, improved handwashing; N, improved nutrition; S, improved sanitation; W, improved water quality; WSH, combined
improvements in water quality, sanitation and handwashing; WSH+N, combined improvements in water quality, sanitation,
handwashing and nutrition.
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College Station, Texas, USA) with a reproducible seed.
Owing to the nature of the interventions, participants
are not blinded to their treatment assignment. Principal
investigators and primary analysts for the trial will
remain blinded to the randomised group assignments
until the primary analysis is complete. Cluster-level
assignments will be under control of each country’s lead
data manager in separate data ﬁles that are independent
from the main datasets of the study. Access to the treat-
ment assignment information (even if blinded), will be
limited to the core analysis team in each country until
the primary results are published.
Sample size
The sample size calculations were based on the two
primary outcomes: LAZ and caregiver-reported diarrhoea.
We calculated the minimum detectable effect for LAZ
measured at 2 years using a standard equation108 and for
diarrhoea using a simulation-based approach to accommo-
date two levels of correlation in the outcome (within child
and within cluster).109 To inform our sample size calcula-
tions we used existing datasets from relevant populations.
In Bangladesh, we used diarrhoea and anthropometric
measurements from 982 children <36 months, collected
from 100 rural villages between 2007 and 2009.110 In
Kenya, we conducted the sample size calculations using
diarrhoea data, collected from 1704 children in 95 control
villages enrolled in a cluster-randomised trial of spring pro-
tection conducted in Western Province between 2005 and
200785; we also conducted the sample size calculation with
LAZ measurements from 310 children 4–30 months old in
a pilot study in our study region. We selected ﬁnal designs
in each country to detect differences of +0.15 in LAZ and
a relative risk of diarrhoea of 0.7 or smaller for a compari-
son of any intervention with the double-sized control arm.
We chose the effect size for LAZ based on our team’s
expert opinion of the smallest effect that would be bio-
logically meaningful and measurable given measurement
error in ﬁeld conditions (+0.15 Z equals 0.48 cm in a
24-month-old girl). We chose the effect size for diarrhoea
based on earlier WASH efﬁcacy studies.111 The control
arm is double sized because it will be used in multiple
hypothesis tests and, given available information, a 2:1 allo-
cation ratio is close to the optimal allocation that mini-
mises the variance for the six tests planned under our ﬁrst
hypothesis, below.112 113 Online supplementary appendix 4
includes the detailed assumptions used in the calculations.
Analysis plan
General analysis approach
Each study team will develop its own analysis plan, but
both teams will include in their analyses unadjusted
Figure 3 Summary of enteric parasite measurement in both countries, including cluster and target child enrolment in each arm.
At enrolment stool specimens will be collected from an older sibling aged 18–27 months if present and will be tested for
protozoan infections. At the final measurement, specimens will be collected from the same older siblings plus seven target
children per cluster in each country, and analysed for protozoan infections and soil-transmitted helminth infections. C, control;
EE, environmental enteropathy; H, improved handwashing; N, improved nutrition; S, improved sanitation; W, improved water
quality; WSH, combined improvements in water quality, sanitation and handwashing; WSH+N, combined improvements in water
quality, sanitation, handwashing and nutrition.
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means and SDs by randomised groups, along with
unadjusted comparisons between groups for the primary
hypotheses.114 115 We will also re-estimate our parameters
of interest in adjusted analyses (details below). We will
produce public replication ﬁles for our primary analyses
in both countries. We will analyse participants according
to their randomised assignment (intention to treat).
Parameters of interest
This section discusses parameters of interest for the
primary analyses. Let Y be an outcome of interest and
let T index the randomised group assignment, where
T[ (C, W, S, H, WSH, N, NWSH). There are seven
arms: C control; W water; S sanitation; H handwashing;
WSH; N nutrition supplement; and NWSH nutrition
plus combined WSH. Let Z be a set of indicators for
matched blocks used in the randomisation. Finally, let ψ
denote parameters of interest. In each comparison
below, we deﬁne ψ as a difference between various ran-
domised groups. For dichotomous outcomes like diar-
rhoea, this implies a risk difference. We will additionally
report risk ratios for dichotomous outcomes as recom-
mended by CONSORT.114
H1: water, sanitation, handwashing, nutrition and
their combination reduce child diarrhoea and improve
linear growth.
The mean outcomes in each active intervention arm
will be compared to the mean outcomes in the control
arm (6 comparisons per outcome). The null hypothesis
is that there is no difference between intervention and
control. The same control group (double sized) will be
used in every comparison. The parameters of interest
are the difference in means between the intervention
groups and the control group. For t[ (W, S, H, WSH,
N, NWSH):
c1;t¼ EZðE[Y jT ¼ t;Z]E[Y jT ¼ C;Z]Þ
H2: when delivered in combination, water, sanitation
and handwashing interventions reduce child diarrhoea
more than when delivered individually
The combined arm (WSH) treatment effect for diar-
rhoea will be compared to individual WASH treatment
effects to determine whether the combined effect is
larger than the individual effects. The parameters of
interest are the difference in means between the com-
bined group and the individual intervention groups. For
t[ ( W, S, H):
c2;t¼ EZðE[Y jT ¼ WSH;Z]E[Y jT ¼ t;Z]Þ
Note that this parameter and associated test differs from
a test for interaction (departure from additive effects).
We expect this study to have limited power to detect
interactions between interventions, but describe tests in
online supplementary appendix 5.
H3: combined nutrition and WASH interventions
reduce diarrhoea and improve linear growth more than
each component alone
We will compare the combined nutrition + WASH arm
(NWSH) treatment effects for growth to the nutrition
arm (N) and the combined WASH arm (WSH). The
null hypothesis is that the treatment effect in the com-
bined arm is equal to the single arms, and the param-
eter of interest is the difference in means between
groups. For t[ (WSH, N):
c3;t¼ EZðE[Y jT ¼ NWSH;Z]E[Y jT ¼ t;Z]Þ
As with H2, this hypothesis is not a hypothesis of inter-
action or synergy. Rather, it is a test to determine
whether one intervention is better than another (addi-
tive interaction would test whether the combined arm is
greater than the sum of the independent intervention
arms). If the interaction were of equal magnitude to the
overall treatment effect, a roughly fourfold increase in
the sample size would be required,116 which would be
logistically infeasible given the already large size of the
trial.
Testing and estimation
One strength of a randomised trial is that it allows inves-
tigators to draw inference non-parametrically, relying
only on randomisation.117 One approach to test for stat-
istical signiﬁcance is a permutation test based on ran-
domly permuting randomised assignments in the data
(following the original randomisation strategy, ie, per-
muting T within strata Z) and re-estimating a test statis-
tic.117–121 We plan to use a rank-based test statistic, which
has been shown to have good power against alterna-
tives,122 and estimate it on unweighted cluster
means.118 119 We will use one-sided tests because we
would only expect the interventions to be beneﬁcial.123
Owing to the relatively small number of tests involved,
we do not plan to adjust the p values for multiple
testing.124
The permutation test is a test for statistical independ-
ence with good power against alternatives but does not
estimate a speciﬁc parameter of interest (and thus will
not provide SEs and CIs for our parameters). Since the
trials depart from an individually randomised design, we
will bootstrap the dataset, resampling clusters in
matched blocks with replacement and re-estimate our
parameters of interest. Resampling matched blocks pre-
serves the correlation structure in the data and retains
any efﬁciency gains from the matched randomisation.
Since we will have a large number of units to resample,
the asymptotic assumptions will be reasonable, the boot-
strap distribution will be smooth and percentile-based
CIs will be accurate for all parameters of interest. We will
examine the bootstrap estimate of the sampling distribu-
tion to conﬁrm these assumptions. The SDs of the boot-
strap distributions will provide estimates of SE.
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We will complement our unadjusted analyses with a
second set of estimates that are conditional on baseline
covariates to potentially increase the efﬁciency of our
analysis and reduce bias from any chance imbalances in
prognostic covariates despite randomisation.125 It is
straightforward to extend permutation tests to include
covariate adjustment while still taking advantage of the
exact distribution theory provided by randomised infer-
ence.118 120 For example, let Yijk be the outcome of inter-
est for individual i in village j and randomisation stratum
k; let Tjk be the randomised intervention indicator and
Xijk be a vector of adjustment covariates. Models are ﬁt
of the form: E[Yijk|Xijk]=m(Xijk), where m(.) is some
function of the covariates X. For example, m(Xijk)
=αk+β ×Xijk+ɛijk for a linear regression, but it could be a
more sophisticated prediction function. The residuals
are then calculated using predicted values of Yijk from
the model:rijk ¼ Yijk  Y^ijk and the permutation test is
conducted on the residuals. The test has nominal size
for the null hypothesis even if the model m(.) is mis-
speciﬁed and if the covariates are measured with
error.118 120 There is no stochastic model for m(.), just a
reduced algorithmic ﬁt; the approach increases statistical
efﬁciency because the residuals are less variable than
the original outcomes, assuming the covariates are
strongly associated with the outcome or heterogeneous
within the strata.118
Following CONSORT guidelines,114 115 we prespecify a
repeatable, objective approach that we will use to iden-
tify adjustment covariates. We plan to consider the fol-
lowing covariates in adjusted models:
▸ Administrative union (Bangladesh) or location
(Kenya);
▸ Field staff team member who recorded the
measurement;
▸ Time between intervention delivery and measurement;
▸ Month of measurement, to account for seasonal
variation;
▸ Household food insecurity;
▸ Child age;
▸ Child sex;
▸ Mother’s age;
▸ Mother’s height;
▸ Mother’s education level and literacy;
▸ Number of children <15 years in the household;
▸ Number of individuals living in the compound;
▸ Distance (in minutes) to the primary water source;
▸ Housing materials (ﬂoor, walls and roof) and house-
hold assets.
We will use a repeatable data-adaptive algorithm to
control for the covariates ﬂexibly and semiparametrically
that will be chosen before the analysis.126 We will calcu-
late adjusted p values using the permutation test
described above based on predicted residuals from the
algorithm. We will estimate SEs and CIs for our para-
meters of interest using the bootstrap described in the
unadjusted analysis section. Online supplementary
appendix 5 includes the details of additional,
prespeciﬁed analyses, including tests of interactions
between interventions, subgroup analyses and tests for
between-cluster spillover effects.
Differential attrition (loss to follow-up): detection and effect
bounds calculation
The study will track enrolled participants carefully to
help minimise attrition. We will compare attrition rates
across randomised arms and also the characteristics of
those lost to follow-up versus those that remain to deter-
mine whether attrition is random. If we ﬁnd systematic
attrition that is not balanced across arms, then we will
conduct sensitivity analyses using ‘worst case’ imputation
bounds for our effect estimates (proposed by Horowitz
and Manski,127 and summarised by Duﬂo et al,108) and
we will also calculate bounds proposed by Lee.128 If
overall levels of attrition approach 20%, we will attempt
to locate individuals who left the study area to measure
outcomes at the 2-year measurement and include them
in our analyses; if attrition is high we will also consider
the use of semiparametric weighting using baseline
characteristics.129
Interim analyses and stopping rules
Interim analyses
Except for monitoring uptake of the interventions
described above, the WASH Beneﬁts study team does
not plan to conduct interim outcome analyses that
include information about randomised assignment until
all of the data from the 2-year measurement are
collected.125 130 131
Negative stopping rule
There is always a risk that interventions will have unin-
tended consequences. Although we would not conduct
the trial if we anticipated such harm, the interventions
are complex and there is always the chance for unantici-
pated outcomes. If one of the country’s Data and Safety
Monitoring Boards (DSMBs) were to ﬁnd clear evidence
of harm based on adverse events, then the study will halt
the harmful intervention arm under international
ethical guidelines for medical research.132
Positive stopping rule
Since this is an efﬁcacy study designed to identify proof
of principle, even if a marked early beneﬁt is identiﬁed
with one or more of the interventions, neither the study
implementers nor the Governments of Bangladesh or
Kenya will be in a position to immediately scale up
effective interventions. Thus, the social beneﬁt of early
stoppage is limited. However, we will provide 1-year
anthropometry measurements to each country’s DSMB.
If at the 1-year measurement, child length for age
Z-score in any of the intervention arms is more than 2
SDs above the control arm we will look to the country’s
DSMB to decide on the appropriateness of continuing
the trial.
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Additional analyses
WASH Beneﬁts is a large study with many collaborators
and the research will be able to answer scientiﬁc ques-
tions beyond those posed in this protocol. Indeed, the
study team expects to conduct and publish analyses that
extend beyond those speciﬁed in this protocol. For
example, objective 5 of the study is to explore the associ-
ation among multiple enteric infection measures col-
lected in the study. Yet, many promising multiplex
antigen assays for parasitic infection are still in develop-
ment and so the study plans to archive samples for
future analyses.
ETHICS AND DISSEMINATION
Each trial is overseen by an independent DSMB, which
review the study protocols and monitor severe adverse
events. All study communities, compounds and care-
givers provide informed consent. The data collected in
the study will be publicly distributed along with meta-
data and critical documents (ie, protocols and question-
naires) following the publication of the primary results
from the trials, which is expected to be within
24 months of the ﬁnal data collection date.
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